Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Limited

Aspen Pharmacare is a global specialty and branded multinational pharmaceutical company that markets and manufactures a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets.

msh id	COM:ASPENPHARMA
symbol	APN
name	Aspen Pharmacare Holdings Limited
homepage url	https://www.aspenpharma.com
country	ZA
sector	Healthcare
industry	Drug Manufacturers - Specialty & Generic
market	STOCKS
employee count	8.61K
crunchbase url	-
linkedin url	-
founders	-

market cap	58.37M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.07
growth cost of revenue	0.1
growth depreciation and amortization	0.04
growth ebitda	-0.01
growth ebitda ratio	-0.06
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.13
growth gross profit	0.01
growth gross profit ratio	-0.05

APN

COM:ASPENPHARMA

Aspen Pharmacare

Last Close

17,130.00

21/11 15:04

Market Cap

1.03B

Beta: -

Volume Today

1.53M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.73B
cost of revenue	1.73B
depreciation and amortization	97.52M
ebitda	576.61M
ebitda ratio	0.26
eps	0.64
eps diluted	0.64
operating expenses	516.23M
operating income	426.62M
operating income ratio	0.19

accounts receivables	17.83M
capital expenditure	-173.49M
cash at beginning of period	271.12M
cash at end of period	408.67M
inventory	1.07B
working capital ttm	21.35B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-